What You Should Know:
– Cancer – the second leading cause of death in the United States – is a complex disease requiring timely diagnosis and treatment. Delays in either can significantly impact patient outcomes.
–…
Continue Reading
What You Should Know:
– OncoHost, a company pioneering personalized medicine approaches for better patient outcomes, announced a collaborative research study with Dana-Farber Cancer Institute, a leading cancer treatment and research center.
– The project aims…
Continue Reading
What You Should Know: – COTA, a leader in real-world data and analytics solutions, today announced a five-year extension of its research collaboration with the U.S. Food and Drug Administration’s (FDA) Oncology Center of…
Continue Reading
The healthcare industry is facing a critical shortage of skilled nuclear radiologists, threatening timely cancer treatment and care. With only 53% of training programs at full enrollment, innovative solutions are needed to address the…
Continue Reading
Background: Wearables measuring vital parameters can be potential tools for monitoring patients at home during cancer treatment. One type of wearable is a smart t-shirt with embedded sensors. Initially, the smart t-shirts were designed…
Continue Reading
What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific…
Continue Reading
Caris Life Sciences Logo
What You Should Know:
– Caris Life Sciences (Caris), a leader in AI-powered precision medicine, and COTA, Inc., a real-world data (RWD) and analytics expert, announced a strategic collaboration today.
– The strategic…
Continue Reading
What You Should Know:
– G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific region)…
Continue Reading
Cloud-based technology has enabled one healthcare provider’s swift transition to a new cancer treatment guideline.The private Sydney Adventist Hospital (the San) in Sydney’s north is an early adopter of the NSW Cancer Institute’s guideline…
Continue Reading
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
